Benzodiazepine and Z-drug consumption in a national social security organization in Argentina: rational or excessive use?

Benzodiazepines and “Z-drugs” (BZD/Z) are overprescribed in many countries. This study evaluates their consumption in a social security sector health insurance provider with national coverage in Argentina. With a descriptive and observational approach, outpatient dispensations of BZD/Zs were analyze...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Gustavo Marin, Julieta Del Mauro, Lupe Marin, Martin A. Urtasun, Gina Marin, Daniel Nucher, Carlos Dacher, Dario Diaz Perez, Martín Cañás
Formato:	article
Lenguaje:	EN ES
Publicado:	Instituto de Salud Colectiva, Universidad Nacional de Lanús 2021
Materias:	benzodiazepines drug utilization pharmacoepidemiology social security argentina Medicine R Public aspects of medicine RA1-1270
Acceso en línea:	https://doaj.org/article/52891a177f0b40498042828086643b0f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:52891a177f0b40498042828086643b0f
record_format	dspace
spelling	oai:doaj.org-article:52891a177f0b40498042828086643b0f2021-11-09T16:40:47ZBenzodiazepine and Z-drug consumption in a national social security organization in Argentina: rational or excessive use?1669-23811851-826510.18294/sc.2021.3583https://doaj.org/article/52891a177f0b40498042828086643b0f2021-09-01T00:00:00Zhttp://revistas.unla.edu.ar/saludcolectiva/article/view/3583https://doaj.org/toc/1669-2381https://doaj.org/toc/1851-8265Benzodiazepines and “Z-drugs” (BZD/Z) are overprescribed in many countries. This study evaluates their consumption in a social security sector health insurance provider with national coverage in Argentina. With a descriptive and observational approach, outpatient dispensations of BZD/Zs were analyzed for people over 18 years old from April 2020 to March 2021, disaggregated by sex, age, active ingredient, and half-life. An annual prevalence of use of 11.6% was found among the 431,445 adult affiliates, with higher rates in women and in those over age 60. Overall consumption of BZD/Zs was 77.6 defined daily doses (DDD) per 1000 enrollee-days. The average user received 5.1 annual dispensations and the equivalent of 1.4 DDD for each day of the year. BZD/Zs with long half-life were the most used. We found high levels of BZD/Z consumption and for longer periods than recommended. It is necessary to improve the quality of consumption and reduce the negative impact of inappropriate use of these drugs among treated individuals.Gustavo MarinJulieta Del MauroLupe MarinMartin A. UrtasunGina MarinDaniel NucherCarlos DacherDario Diaz PerezMartín CañásInstituto de Salud Colectiva, Universidad Nacional de Lanúsarticlebenzodiazepinesdrug utilizationpharmacoepidemiologysocial securityargentinaMedicineRPublic aspects of medicineRA1-1270ENESSalud Colectiva, Vol 17, Pp e3583-e3583 (2021)
institution	DOAJ
collection	DOAJ
language	EN ES
topic	benzodiazepines drug utilization pharmacoepidemiology social security argentina Medicine R Public aspects of medicine RA1-1270
spellingShingle	benzodiazepines drug utilization pharmacoepidemiology social security argentina Medicine R Public aspects of medicine RA1-1270 Gustavo Marin Julieta Del Mauro Lupe Marin Martin A. Urtasun Gina Marin Daniel Nucher Carlos Dacher Dario Diaz Perez Martín Cañás Benzodiazepine and Z-drug consumption in a national social security organization in Argentina: rational or excessive use?
description	Benzodiazepines and “Z-drugs” (BZD/Z) are overprescribed in many countries. This study evaluates their consumption in a social security sector health insurance provider with national coverage in Argentina. With a descriptive and observational approach, outpatient dispensations of BZD/Zs were analyzed for people over 18 years old from April 2020 to March 2021, disaggregated by sex, age, active ingredient, and half-life. An annual prevalence of use of 11.6% was found among the 431,445 adult affiliates, with higher rates in women and in those over age 60. Overall consumption of BZD/Zs was 77.6 defined daily doses (DDD) per 1000 enrollee-days. The average user received 5.1 annual dispensations and the equivalent of 1.4 DDD for each day of the year. BZD/Zs with long half-life were the most used. We found high levels of BZD/Z consumption and for longer periods than recommended. It is necessary to improve the quality of consumption and reduce the negative impact of inappropriate use of these drugs among treated individuals.
format	article
author	Gustavo Marin Julieta Del Mauro Lupe Marin Martin A. Urtasun Gina Marin Daniel Nucher Carlos Dacher Dario Diaz Perez Martín Cañás
author_facet	Gustavo Marin Julieta Del Mauro Lupe Marin Martin A. Urtasun Gina Marin Daniel Nucher Carlos Dacher Dario Diaz Perez Martín Cañás
author_sort	Gustavo Marin
title	Benzodiazepine and Z-drug consumption in a national social security organization in Argentina: rational or excessive use?
title_short	Benzodiazepine and Z-drug consumption in a national social security organization in Argentina: rational or excessive use?
title_full	Benzodiazepine and Z-drug consumption in a national social security organization in Argentina: rational or excessive use?
title_fullStr	Benzodiazepine and Z-drug consumption in a national social security organization in Argentina: rational or excessive use?
title_full_unstemmed	Benzodiazepine and Z-drug consumption in a national social security organization in Argentina: rational or excessive use?
title_sort	benzodiazepine and z-drug consumption in a national social security organization in argentina: rational or excessive use?
publisher	Instituto de Salud Colectiva, Universidad Nacional de Lanús
publishDate	2021
url	https://doaj.org/article/52891a177f0b40498042828086643b0f
work_keys_str_mv	AT gustavomarin benzodiazepineandzdrugconsumptioninanationalsocialsecurityorganizationinargentinarationalorexcessiveuse AT julietadelmauro benzodiazepineandzdrugconsumptioninanationalsocialsecurityorganizationinargentinarationalorexcessiveuse AT lupemarin benzodiazepineandzdrugconsumptioninanationalsocialsecurityorganizationinargentinarationalorexcessiveuse AT martinaurtasun benzodiazepineandzdrugconsumptioninanationalsocialsecurityorganizationinargentinarationalorexcessiveuse AT ginamarin benzodiazepineandzdrugconsumptioninanationalsocialsecurityorganizationinargentinarationalorexcessiveuse AT danielnucher benzodiazepineandzdrugconsumptioninanationalsocialsecurityorganizationinargentinarationalorexcessiveuse AT carlosdacher benzodiazepineandzdrugconsumptioninanationalsocialsecurityorganizationinargentinarationalorexcessiveuse AT dariodiazperez benzodiazepineandzdrugconsumptioninanationalsocialsecurityorganizationinargentinarationalorexcessiveuse AT martincanas benzodiazepineandzdrugconsumptioninanationalsocialsecurityorganizationinargentinarationalorexcessiveuse
_version_	1718440926104256512

Benzodiazepine and Z-drug consumption in a national social security organization in Argentina: rational or excessive use?

Ejemplares similares